May 22, 2025

News provided by Share this article EQUASHIELD® Ranked as #1 Closed System Transfer Device in Use in the US For Preparation PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ranked as the #1 CSTD used in US pharmacies for the seventh consecutive year by Pharmacy Purchasing & Products. This milestone highlights EQUASHIELD®'s commitment to innovation, safety, and efficiency in protecting healthcare workers from hazardous drug exposure. The recognition reaffirms EQUASHIELD®'s reputation for delivering advanced solutions that support the safe compounding and administration of hazardous drugs. Since its inception, EQUASHIELD® has remained a trusted partner in thousands of healthcare facilities worldwide, earning the loyalty of pharmacy professionals through its unparalleled safety features, ease of use, and efficient workflows. "Our dedication to enhancing safety and efficiency in pharmacy operations remains strong year after year. This achievement underscores that commitment and reflects the trust placed in us by healthcare professionals across the country," said Jason Dutcher, Director of Strategic Accounts of EQUASHIELD®. "We are deeply grateful to our partners and customers who share our mission of reducing occupational risks and improving safety standards." EQUASHIELD® owes much of its success to its innovative closed-back Syringe Unit, a patented design that effectively contains hazardous drug aerosols and vapors during compounding and administration. The EQUASHIELD® Syringe unit features a pre-bonded connector and an encapsulated plunger rod, which enhance usability and safety. These elements help prevent accidental disconnections, contamination, and spills, ensuring safer handling of hazardous drugs for healthcare professionals. EQUASHIELD®'s robust suite of products is known for addressing key routes of exposure, meeting stringent safety benchmarks, and being easy to deploy, fostering their widespread adoption in the US and globally. EQUASHIELD®'s innovative Pharmacy Automation solutions have also continued to evolve, introducing advanced technologies that streamline hazardous drug handling and compounding processes. By integrating robotic automation into pharmacy workflows, EQUASHIELD® Mundus Mini HD reduces human error and ensures precise, contamination-free compounding, providing an added layer of safety for healthcare professionals and patients alike. "Seven years at the top is no small feat," Dutcher added. "This continued success comes from our relentless focus on research and development, listening to our customers, and delivering solutions that address their most pressing needs." With an eye on the future, EQUASHIELD® remains committed to driving advancements in healthcare technology and fostering safer environments for all healthcare workers. For more information about EQUASHIELD® and its industry-leading CSTD and pharmacy automation solutions, please visit www.EQUASHIELD.com . About EQUASHIELD® EQUASHIELD® is a leading provider of manual and automated solutions for the compounding and administration of hazardous drugs. EQUASHIELD®'s CSTD is clinically proven to protect healthcare professionals from hazardous drug exposure. It covers more routes of exposure than alternative systems and has passed the proposed 2015 alcohol vapor containment protocol from NIOSH, confirming that it can contain the harshest vapors and emissions. Studies have shown EQUASHIELD®'s CSTD as faster to deploy and easier to use than competing systems. Used by hundreds of hospitals and clinics around the world, EQUASHIELD® is substantiated by the FDA for preventing microbial ingress for up to seven days. For Media Inquiries: